Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The credibility of industry-sponsored clinical research has suffered in recent years, undercut by reports of selective or biased disclosure of research results, ghostwriting and guest authorship, and inaccurate or incomplete reporting of potential conflicts of interest.1,2 In response, many pharmaceutical companies have integrated best practices and recommendations from groups such as the International Committee of Medical Journal Editors (ICMJE), the Good Publication Practice guidelines, the Committee on Publication Ethics, the EQUATOR (Enhancing the QUAlity and Transparency Of health Resources) Network, and the Medical Publishing Insights and Practices (MPIP) initiative into their internal policies and standard operating procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Ross, J. S., Tse, T., Zarin, D. A., Xu, H., Zhou, L., & Krumholz, H. M. (2012) · BMJ · doi:10.1136/bmj.d7292 · Cited by 371
Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results
Chan, A.-W. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050230 · Cited by 144 · cited 1×
“Some journals request submission of a clinical study protocol to validate methods and end points used in submitted manuscripts, screen for analysis or reporting errors, confirm that the manuscript matches the protocol, and verify that any protocol amendments do not affect study conduct or integrity inappropriately.(27…”
Cited by
Increasing value and reducing waste: addressing inaccessible research
Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62296-5 · Cited by 887
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C. I., Citrome, L., Gurr, J. A., Mooney, L. A., Moore, B. J., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0288 · Cited by 358
Self-citationGood Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
DeTora, L. M., Toroser, D., Sykes, A., Vanderlinden, C., Plunkett, F. J., Lane, T., Hanekamp, E., Dormer, L., DiBiasi, F., Bridges, D., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1460 · Cited by 258
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps
Jarvis, M. F., & Williams, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.12.001 · Cited by 129
“[15] and Begley and Ellis [16] to be a primary contributor to shortfalls in drug discovery and development [2–6] and that clinical trials are inherently better designed and controlled than most experiments in preclinical research [7,63], despite considerable evidence to the contrary [64–66].”
BackgroundCepeda, M. S., Berlin, J. A., Glasser, S. C., Battisti, W. P., & Schuemie, M. J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0085-9 · Cited by 11
Self-citation
Metadata
- Authors
- Mansi, B. A., Clark, J., David, F. S., Gesell, T. M., Glasser, S., Gonzalez, J., Haller, D. G., Laine, C., Miller, C. L., Mooney, L. A., & Zecevic, M.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 87
- Issue
- 5
- Pages
- 424-429
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2058042981
- Cited by
- 62
- References
- 2
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective. https://app.cochat.ai/papers/10.1016/j.mayocp.2012.02.009
- The paper
- Mansi, B. A., Clark, J., David, F. S., Gesell, T. M., Glasser, S., Gonzalez, J., Haller, D. G., Laine, C., Miller, C. L., Mooney, L. A., & Zecevic, M. (2012). Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2012.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.